
Pro Medicus signs $128M NYC Health deal
Pontos principais
- Pro Medicus signed a 10-year, $128 million contract with NYC Health + Hospitals through its U.S. subsidiary, Visage Imaging.
- Shares in Pro Medicus traded unchanged at $192.55.
- The company will deploy its cloud-based Visage 7 imaging platform across the health system to replace legacy archives.
Pro Medicus (ASX:PME) announced that its U.S. subsidiary signed a 10-year, $128 million contract with NYC Health + Hospitals.
This agreement adds to a string of recent U.S. hospital deals, following a $43 million contract with Virtual Health and a $24 million deal with Billings Clinic in October.
The transaction-based agreement covers the full Visage 7 software suite, with system rollout targeted for late in the third quarter of 2027.
The company stated that the contract includes migrating legacy imaging archives to its Visage 7 Open Archive and integrating image distribution into the hospital system's electronic health record.
Following the announcement, the Pro Medicus share price was unchanged at $192.55.
Pro Medicus develops medical imaging software and relies on multi-year, cloud-based contracts in North America, where it generated 90% of its fiscal 2026 revenue.
Over recent months, the company also secured a $25 million deal with Valley Health and a $23 million contract with St Luke's Health System and reported a 22.9% rise in full-year revenue to $261.7 million.
